TITLE

Overexpression of CD97 Confers an Invasive Phenotype in Glioblastoma Cells and Is Associated with Decreased Survival of Glioblastoma Patients

AUTHOR(S)
Safaee, Michael; Clark, Aaron J.; Oh, Michael C.; Ivan, Michael E.; Bloch, Orin; Kaur, Gurvinder; Sun, Matthew Z.; Kim, Joseph M.; Oh, Taemin; Berger, Mitchel S.; Parsa, Andrew T.
PUB. DATE
April 2013
SOURCE
PLoS ONE;Apr2013, Vol. 8 Issue 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Mechanisms of invasion in glioblastoma (GBM) relate to differential expression of proteins conferring increased motility and penetration of the extracellular matrix. CD97 is a member of the epidermal growth factor seven-span transmembrane family of adhesion G-protein coupled receptors. These proteins facilitate mobility of leukocytes into tissue. In this study we show that CD97 is expressed in glioma, has functional effects on invasion, and is associated with poor overall survival. Glioma cell lines and low passage primary cultures were analyzed. Functional significance was assessed by transient knockdown using siRNA targeting CD97 or a non-target control sequence. Invasion was assessed 48 hours after siRNA-mediated knockdown using a Matrigel-coated invasion chamber. Migration was quantified using a scratch assay over 12 hours. Proliferation was measured 24 and 48 hours after confirmed protein knockdown. GBM cell lines and primary cultures were found to express CD97. Knockdown of CD97 decreased invasion and migration in GBM cell lines, with no difference in proliferation. Gene-expression based Kaplan-Meier analysis was performed using The Cancer Genome Atlas, demonstrating an inverse relationship between CD97 expression and survival. GBMs expressing high levels of CD97 were associated with decreased survival compared to those with low CD97 (p = 0.007). CD97 promotes invasion and migration in GBM, but has no effect on tumor proliferation. This phenotype may explain the discrepancy in survival between high and low CD97-expressing tumors. This data provides impetus for further studies to determine its viability as a therapeutic target in the treatment of GBM.
ACCESSION #
87679296

 

Related Articles

  • Melanoma Cell Invasiveness Is Promoted at Least in Part by the Epidermal Growth Factor-Like Repeats of Tenascin-C. Grahovac, Jelena; Becker, Dorothea; Wells, Alan // Journal of Investigative Dermatology;Jan2013, Vol. 133 Issue 1, p210 

    Tenascin-C (TNC), overexpressed in invasive growths, has been implicated in progression of melanoma, but the source and function of this molecule are not well defined. We found TNC expression at the front of invading melanoma cells, and that adding TNC to matrices enhances individual melanoma...

  • COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration. Boudot, Antoine; Kerdivel, Gwenneg; Lecomte, Sylvain; Flouriot, Gilles; Desille, Mireille; Godey, Florence; Leveque, Jean; Tas, Patrick; Le Dréan, Yves; Pakdel, Farzad // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background The orphan receptors COUP-TF (chicken ovalbumin upstream promoter transcription factor) I and II are members of the nuclear receptor superfamily that play distinct and critical roles in vertebrate organogenesis. The involvement of COUP-TFs in cancer development has recently been...

  • MolecularMechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer. Fiszman, Gabriel L.; Jasnis, María A. // International Journal of Breast Cancer;2011, p1 

    The epidermal growth factor receptor 2 (HER2) is a tyrosine kinase overexpressed in nearly 20% to 25% of invasive breast cancers. Trastuzumab is a humanized monoclonal antibody that targets HER2. The majority of patients with metastatic breast cancer initially respond to trastuzumab, however,...

  • Targeting ErbB Receptors in High-Grade Glioma. Berezowska, Sabina; Schlegel, Jürgen // Current Pharmaceutical Design;8/1/2011, Vol. 17 Issue 23, p2468 

    High-grade gliomas, including glioblastoma, are among the most malignant and treatment-refractory human neoplasms. The tumors show high levels of resistance to conventional therapies (i.e. surgery, irradiation, and chemotherapy), and despite treatment advances patient outcome remains poor. New...

  • Expression and Functional Role of Sprouty-2 in Breast Morphogenesis. Sigurdsson, Valgardur; Ingthorsson, Saevar; Hilmarsdottir, Bylgja; Gustafsdottir, Sigrun M.; Franzdottir, Sigridur Rut; Arason, Ari Jon; Steingrimsson, Eirikur; Magnusson, Magnus K.; Gudjonsson, Thorarinn // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Branching morphogenesis is a mechanism used by many species for organogenesis and tissue maintenance. Receptor tyrosine kinases (RTKs), including epidermal growth factor receptor (EGFR) and the sprouty protein family are believed to be critical regulators of branching morphogenesis. The aim of...

  • Deletion of the SPARC acidic domain or EGF-like module reduces SPARC-induced migration and signaling through p38 MAPK/HSP27 in glioma. McClung, Heather M.; Golembieski, William A.; Schultz, Chad R.; Jankowski, Michelle; Schultz, Lonni R.; Rempel, Sandra A. // Carcinogenesis;Feb2012, Vol. 33 Issue 2, p275 

    We previously demonstrated that secreted protein acidic and rich in cysteine (SPARC) increases heat shock protein 27 (HSP27) expression and phosphorylation and promotes glioma cell migration through the p38 mitogen-activated protein kinase (MAPK)/HSP27 signaling pathway. As different regions of...

  • The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways. Badgwell, D B; Lu, Z; Le, K; Gao, F; Yang, M; Suh, G K; Bao, J-J; Das, P; Andreeff, M; Chen, W; Yu, Y; Ahmed, A A; S-L Liao, W; Bast, R C // Oncogene;1/5/2012, Vol. 31 Issue 1, p68 

    Ovarian cancers migrate and metastasize over the surface of the peritoneal cavity. Consequently, dysregulation of mechanisms that limit cell migration may be particularly important in the pathogenesis of the disease. ARHI is an imprinted tumor-suppressor gene that is downregulated in >60% of...

  • Ameloblastin Inhibits Cranial Suture Closure by Modulating Msx2 Expression and Proliferation. Atsawasuwan, Phimon; Lu, Xuanyu; Ito, Yoshihiro; Zhang, Youbin; Evans, Carla A.; Luan, Xianghong // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Deformities of cranial sutures such as craniosynostosis and enlarged parietal foramina greatly impact human development and quality of life. Here we have examined the role of the extracellular matrix protein ameloblastin (Ambn), a recent addition to the family of non-collagenous extracellular...

  • Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells. Cheng, J-C; Chang, H-M; Leung, P C K // Oncogene;2/21/2013, Vol. 32 Issue 8, p1041 

    Loss of the cell adhesion protein E-cadherin increases the invasive capability of ovarian cancer cells. We have previously shown that epidermal growth factor (EGF) downregulates E-cadherin and induces ovarian cancer cell invasion through the H2O2/p38 MAPK-mediated upregulation of the E-cadherin...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics